Business Standard
Home / India News / Zydus Cadila receives final approval for Felbamate Tablets

Zydus Cadila receives final approval for Felbamate Tablets

Image

Capital Market
Last Updated : May 31 2017 | 7:01 PM IST

From USFDA

Zydus Cadila has received final approval from USFDA to market Felbamate Tablets USP in strengths of 400 mg and 600 mg.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

Also Read

Zydus Cadila receives final approval for Cyproheptadine Hydrochloride Tablets USP

Zydus Cadila receives final approval for Cyproheptadine Hydrochloride Tablets USP

Zydus receives final approval for Olmesartan Medoxomil Tablets

Zydus receives final approval for Olmesartan Medoxomil Tablets

Zydus Cadila receives USFDA nod to market fluconazole tablets

Zydus Cadila receives USFDA nod to market fluconazole tablets

Cadila Healthcare gains after receiving final approval for Methotrexate tablets

Cadila Healthcare gains after receiving final approval for Methotrexate tablets

Alembic Pharmaceuticals receives final approval for Olmesartan Medoxomil Tablets & Medoxomil with Hydrochlorothiazide Tablets

Alembic Pharmaceuticals receives final approval for Olmesartan Medoxomil Tablets & Medoxomil with Hydrochlorothiazide Tablets

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: May 31 2017 | 6:53 PM IST

Explore News

Market LIVEParliament Winter Session 2024 LIVELatest News LIVEMarket TodayStocks To Watch TodayMobikwik IPO listingIGI IPO AllotmentIND vs AUS 3rd Test Day 5 LIVEIPO NewsBusiness Standard at 50
HOT STOCKS
TOP SECTIONS
KEY EVENTS
Copyrights © 2024 Business Standard Private Ltd. All rights reserved
LinkedIN Icon